Publisher Correction: COVID-19 antibodies on trial

The Original Article was published on 21 October 2020

Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-020-0732-8, published online 21 October 2020.

In the version of this article initially published, LY-CoV555 was described in the introductory paragraph as a cocktail of two mAbs. It is a single mAb. The error has been corrected in the PDF and HTML versions of the article.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Laura DeFrancesco.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

DeFrancesco, L. Publisher Correction: COVID-19 antibodies on trial. Nat Biotechnol (2021). https://doi.org/10.1038/s41587-021-00813-x

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing